SCHEMBL5495779

SCHEMBL5495779

Nc1ccn2ncccc12

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 6/20 0.44
SMPD3 Q9NY59 2/20 0.35
RPS6KA5 O75582 2/20 0.35
CDC7 O00311 2/20 0.35
CDK2 P24941 2/20 0.35
DYRK1A Q13627 2/20 0.34
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
IDO1 P14902 1/20 0.31
PSMB5 P28074 1/20 0.31
ROCK1 Q13464 1/20 0.30
EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30489874 0.82 MAP4K4 (0.53) MAP4K4SMPD3RPS6KA5CDC7CDK2
SCHEMBL2849280 0.77 MAP4K4 (0.53) MAP4K4SMPD3DYRK1AKDM4EGAA
SCHEMBL17847672 0.76 MAP4K4 (0.38) MAP4K4SMPD3DYRK1AKDM4EGAA
SCHEMBL29416290 0.73 NOTUM (0.36) MAP4K4RPS6KA5DYRK1AGAAEGFR
SCHEMBL13660727 0.73 MAP4K4 (0.36) MAP4K4RPS6KA5DYRK1AALDH1A1HTT
SCHEMBL18805605 0.73 MAP4K4 (0.36) MAP4K4RPS6KA5DYRK1AKDM4EALDH1A1
SCHEMBL25421804 0.72 MAP4K4 (0.36) MAP4K4SMPD3DYRK1A
SCHEMBL31291221 0.72 MAP4K4 (0.36) MAP4K4SMPD3DYRK1AALDH1A1
SCHEMBL31291220 0.72 MAP4K4 (0.36) MAP4K4SMPD3DYRK1AALDH1A1
SCHEMBL6745049 0.72 MAP4K4 (0.36) MAP4K4SMPD3DYRK1AHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025898-A1 HPK1 ANTAGONISTS AND USES THEREOF SCHRÖDINGER, INC. 2024-01-25 US disclosed
US-7306631-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-12-11 US disclosed
CN-1937995-A Keratin dyeing compositions comprising bicyclic 5-6 heteroaromatic dyeing compounds containing a ring-connected nitrogen atom PROCTER & GAMBLE (US) 2007-03-28 CN disclosed
EP-1732509-A1 KERATIN DYEING COMPOSITIONS BICYCLIC 5-6 HETEROAROMATIC DYEING COMPOUNDS WITH ONE RING NITROGEN JUNCTION The Procter and Gamble Company (US) 2006-12-20 EP disclosed
WO-2005097052-A1 KERATIN DYEING COMPOSITIONS BICYCLIC 5-6 HETEROAROMATIC DYEING COMPOUNDS WITH ONE RING NITROGEN JUNCTION THE PROCTER & GAMBLE COMPANY (US) 2005-10-20 WO disclosed
US-20050229333-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025898-A1 HPK1 ANTAGONISTS AND USES THEREOF PDXK, HIPK1, PCK1 MAP4K4 145/4885SMPD3 1495/4885RPS6KA5 333/4885
US-20050229333-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, JUP MAP4K4 714/4885SMPD3 4766/4885RPS6KA5 1268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.